HomeERNA • NASDAQ
add
Ernexa Therapeutics Inc
Previous close
$1.31
Day range
$1.25 - $1.29
Year range
$1.09 - $14.40
Market cap
10.05M USD
Avg Volume
51.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.99M | -54.52% |
Net income | -1.24M | 95.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.98M | 47.97% |
Effective tax rate | -0.49% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.05M | -28.54% |
Total assets | 6.17M | -20.03% |
Total liabilities | 2.60M | -95.10% |
Total equity | 3.57M | — |
Shares outstanding | 7.85M | — |
Price to book | 2.91 | — |
Return on assets | -72.44% | — |
Return on capital | -108.80% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.24M | 95.34% |
Cash from operations | -1.27M | 79.76% |
Cash from investing | -22.00K | -15.79% |
Cash from financing | 26.00K | -99.33% |
Net change in cash | -1.27M | 47.54% |
Free cash flow | -1.26M | 7.85% |
About
Founded
2018
Headquarters
Website
Employees
6
